-
1
-
-
70349454206
-
Validation of a new simple scale to measure symptoms in atrial fibrillation: The Canadian Cardiovascular Society severity in atrial fibrillation scale Circ
-
Dorian P, Guerra PG, Kerr CR, O'Donnell SS, Crystal E, Gillis AM et al. Validation of a new simple scale to measure symptoms in atrial fibrillation: The Canadian Cardiovascular Society severity in atrial fibrillation scale Circ. Arrhythmia Electrophysiol 2009;2:218-24.
-
(2009)
Arrhythmia Electrophysiol
, vol.2
, pp. 218-224
-
-
Dorian, P.1
Guerra, P.G.2
Kerr, C.R.3
O'Donnell, S.S.4
Crystal, E.5
Gillis, A.M.6
-
2
-
-
60549097431
-
Effect of Dronedarone on cardiovascular events in atrial fibrillation
-
Hohnloser SH, Crijns HJ, Van Eickels M, Gaudin C, Page RL, Torp-Pedersen C. Effect of Dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009;360:668-78.
-
(2009)
N Engl J Med
, vol.360
, pp. 668-678
-
-
Hohnloser, S.H.1
Crijns, H.J.2
Van Eickels, M.3
Gaudin, C.4
Page, R.L.5
Torp-Pedersen, C.6
-
3
-
-
80051724296
-
Impact of Dronedarone on hospitalization burden in patients with atrial fibrillation: Results from the ATHENA study
-
Torp-Pedersen C, Crijns HJGM, Gaudin C, Page RL, Connolly SJ, Hohnloser SH. Impact of Dronedarone on hospitalization burden in patients with atrial fibrillation: Results from the ATHENA study. Europace 2011;13:1118-26.
-
(2011)
Europace
, vol.13
, pp. 1118-1126
-
-
Torp-Pedersen, C.1
Crijns, H.J.G.M.2
Gaudin, C.3
Page, R.L.4
Connolly, S.J.5
Hohnloser, S.H.6
-
4
-
-
37549001334
-
Rational and design of ATHENA: A placebo controlled, double blind, parallel arm trial to assess the efficacy of Dronedarone 400 mg bid for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter
-
Hohnloser SH, Connolly SJ, Crijns HJ, Page RL, Seiz W, Torp-Pedersen C. Rational and design of ATHENA: A placebo controlled, double blind, parallel arm trial to assess the efficacy of Dronedarone 400 mg bid for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter. J Cardiovasc Electrophysiol 2008;19:69-73.
-
(2008)
J Cardiovasc Electrophysiol
, vol.19
, pp. 69-73
-
-
Hohnloser, S.H.1
Connolly, S.J.2
Crijns, H.J.3
Page, R.L.4
Seiz, W.5
Torp-Pedersen, C.6
-
5
-
-
0348047552
-
Cost of care distribution in atrial fibrillation patients: The COCAF study
-
DOI 10.1016/S0002-8703(03)00524-6
-
Le Heuzey JY, Paziaud O, Piot O, Ait Said M, Copie X, Lavergne T, Guize L. Cost Of Care distribution in Atrial Fibrillation patients : The COCAF study. Am Heart J 2004;147:121-6. (Pubitemid 38037407)
-
(2004)
American Heart Journal
, vol.147
, Issue.1
, pp. 121-126
-
-
Le Heuzey, J.-Y.1
Paziaud, O.2
Piot, O.3
Said, M.A.4
Copie, X.5
Lavergne, T.6
Guize, L.7
-
6
-
-
77952604921
-
A short term randomised double blind, parallel group study to evaluate the efficacy and safety of Dronedarone versus Amiodarone in patients with persistent atrial fibrillation: The DIONYSOS study
-
Le Heuzey JY, De Ferrari GM, Radzik D, Santini M, Zhu J, Davy JM. A short term randomised double blind, parallel group study to evaluate the efficacy and safety of Dronedarone versus Amiodarone in patients with persistent atrial fibrillation: The DIONYSOS study. J Cardiovasc Electrophysiol 2010;21:597-605.
-
(2010)
J Cardiovasc Electrophysiol
, vol.21
, pp. 597-605
-
-
Le Heuzey, J.Y.1
De Ferrari, G.M.2
Radzik, D.3
Santini, M.4
Zhu, J.5
Davy, J.M.6
|